Are you currently compounding with any hazardous active pharmaceutical ingredients such as apomorphone, azathioprin, cyclophosphamide, cyclosporine, diethylstilbestrol, estradiol, fluorouracil, medroxyprogesterone, phenytoin, progesterone, spironolactone, or tacrolimus?
If so, you must be compliant with General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings, which was formally published February 1, 2016 in the First Supplement to USP 39-NF 34. In an effort to provide an adequate timeframe to implement USP <800>, the chapter has a delayed official implementation date of July 1, 20181. While a two-year window may seem to provide sufficient time for preparation, it is important to note that this implementation date is when entities must be compliant; waiting too long to begin the process could negatively impact your practice.
Explore hazardous chemicals, devices and equipment for use with hazardous compounding, and find answers to frequently asked questions about USP <800> and hazardous compounding.
View a list of the drugs supplied by MEDISCA that are currently on the NIOSH list of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, like testosterone, progesterone, among others.
Special precautions must be taken when handling hazardous chemicals. Learn more about the equipment and devices that can help prevent or minimize your exposure. Our products include personal protective equipment, closed system transfer devices, emergency equipment, deactivation agents, and more.
What is hazardous compounding? Who needs to comply with USP <800>? What kind of equipment do I need to use with hazardous chemicals? Find in our FAQ section answers to common questions about being compliant with USP <800> and how it will impact your compounding pharmacy practice.
1On September 29th, 2017 USP released a notification of intent to revise the official implementation date of USP General Chapter <800> to December 1, 2019.
Sign up for free email updates to receive the latest news about products, services and events from MEDISCA.
Participate in our MD Dispenser survey now!
You have successfully added to the cart.
Please note that MEDISCA will no longer accept any returns and will not issue any credits for active pharmaceutical ingredients (APIs).
Copyright® 1986-2018 Medisca Inc.
All rights reserved
Back to Top